Ligand to Receive $3 Million as Royalty Pharma Exercises First Option to Purchase Additional Rights to Future SERM Royalty Streams

San Diego, CA - April 18, 2002


© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.